Can a cancer therapy help treat autoimmune diseases?
About this episode
This episode explores the potential of CAR-T cell therapy in treating autoimmune diseases, highlighting a recent case of treatment-free remission.
CAR-T cell therapy, a breakthrough treatment that has transformed certain cancer outcomes, is now showing early promise in tackling autoimmune diseases. In a recent case in Germany, a patient with multiple severe autoimmune conditions entered treatment-free remission after receiving the therapy, raising fresh questions about its potential beyond cancer. In this episode, we break down how CAR-T works, why autoimmune diseases are so difficult to treat, and whether this approach could offer long-term remission or even a cure. We also look at the risks, costs and what this could mean for patients in India. Host: Reuben Joe Joseph Guest: Roshan Samuel Mathews, PhD candidate, Albert Einstein College of Medicine, New York Edited and produced by Sharmada Venkatasubramanian Learn more about your ad choices. Visit megaphone.fm/adchoices
People in this episode
Host: Reuben Joe Joseph
Guest: Roshan Samuel Mathews
Topics covered
- cancer therapy
- autoimmune diseases
- CAR-T cell therapy
- treatment remission
- medical research
Keywords
- CAR-T cell therapy
- autoimmune diseases
- treatment remission
- cancer therapy
- medical research
Mentioned in this episode
Organizations: Albert Einstein College of Medicine
Places: Germany, India
More episodes of In Focus by The Hindu
- Why are Haryana's farmers resisting the new digital verification rules at mandis?
- In Focus-Weekend | How AI could reshape the future of species
- Noida protest: Why do labour disputes get treated as ‘law and order’ issue?
- In Focus-Parley | Has a weakening of unionisation hurt workers?
- How to make India's metro systems serve our cities better?
- How will 'Indian Ozempics' change treatment for diabetes and obesity?
Explore listener stats, chart rankings, contacts and more on the In Focus by The Hindu podcast page.